Alex Cazes

587 total citations
9 papers, 336 citations indexed

About

Alex Cazes is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Alex Cazes has authored 9 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Alex Cazes's work include Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Lung Cancer Research Studies (3 papers). Alex Cazes is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Lung Cancer Research Studies (3 papers). Alex Cazes collaborates with scholars based in France, United States and Sweden. Alex Cazes's co-authors include Thomas G. P. Grünewald, Martin F. Orth, Elke Butt, Isabelle Janoueix‐Lerosey, Olivier Delattre, Valérie Combaret, Marc Vigny, Pierre Mazot, Caroline Louis‐Brennetot and Andrew M. Lowy and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Alex Cazes

9 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Cazes France	9	206	145	107	102	43	9	336
Damini Chand United States	9	153 0.7×	128 0.9×	110 1.0×	71 0.7×	82 1.9×	12	321
Crocifissa Lo Cunsolo Italy	10	227 1.1×	175 1.2×	119 1.1×	103 1.0×	52 1.2×	17	412
Annika Sprüssel Germany	9	343 1.7×	144 1.0×	89 0.8×	153 1.5×	29 0.7×	10	477
Cinthia Amiñoso Spain	12	233 1.1×	141 1.0×	62 0.6×	79 0.8×	43 1.0×	18	409
Mariko DeWire United States	14	194 0.9×	125 0.9×	60 0.6×	57 0.6×	90 2.1×	23	416
Robyn T. Sussman United States	11	331 1.6×	48 0.3×	160 1.5×	106 1.0×	61 1.4×	24	468
Erin R. Okawa United States	8	338 1.6×	198 1.4×	86 0.8×	134 1.3×	20 0.5×	13	492
Jennifer Elster United States	8	150 0.7×	103 0.7×	60 0.6×	69 0.7×	51 1.2×	26	325
Roxanne Marshall United States	5	199 1.0×	54 0.4×	87 0.8×	152 1.5×	87 2.0×	6	433
Ali Fuat Okuducu Germany	12	161 0.8×	135 0.9×	91 0.9×	113 1.1×	127 3.0×	19	426

Countries citing papers authored by Alex Cazes

Since Specialization

Citations

This map shows the geographic impact of Alex Cazes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Cazes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Cazes more than expected).

Fields of papers citing papers by Alex Cazes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Cazes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Cazes. The network helps show where Alex Cazes may publish in the future.

Co-authorship network of co-authors of Alex Cazes

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Cazes. A scholar is included among the top collaborators of Alex Cazes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Cazes. Alex Cazes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Cazes, Alex, et al.. (2022). The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies. Cancers. 14(8). 2037–2037. 21 indexed citations

Cazes, Alex, Oscar Betancourt, Evangeline Mose, et al.. (2021). A MET Targeting Antibody–Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer. Clinical Cancer Research. 27(7). 2100–2110. 28 indexed citations

Provost, C., Aurélie Prignon, Alex Cazes, et al.. (2016). 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models. Anticancer Research. 36(9). 4459–4466. 8 indexed citations

Orth, Martin F., Alex Cazes, Elke Butt, & Thomas G. P. Grünewald. (2014). An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein. Oncotarget. 6(1). 26–42. 63 indexed citations

Cazes, Alex, Lucille Lopez‐Delisle, Konstantina Tsarovina, et al.. (2014). Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma. Oncotarget. 5(9). 2688–2702. 73 indexed citations

Boeva, Valentina, Stéphanie Jouannet, Romain Daveau, et al.. (2013). Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis. PLoS ONE. 8(8). e72182–e72182. 28 indexed citations

Cazes, Alex, Caroline Louis‐Brennetot, Pierre Mazot, et al.. (2012). Characterization of Rearrangements Involving the ALK Gene Reveals a Novel Truncated Form Associated with Tumor Aggressiveness in Neuroblastoma. Cancer Research. 73(1). 195–204. 44 indexed citations

Mazot, Pierre, Alex Cazes, Florent Dingli, et al.. (2012). Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment. PLoS ONE. 7(3). e33581–e33581. 25 indexed citations

Mazot, Pierre, Alex Cazes, Marie‐Claude Boutterin, et al.. (2011). The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking. Oncogene. 30(17). 2017–2025. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact